Literature DB >> 9327740

HOXC4, HOXC5, and HOXC6 expression in primary cutaneous lymphoid lesions. High expression of HOXC5 in anaplastic large-cell lymphomas.

J J Bijl1, E Rieger, J W van Oostveen, J M Walboomers, M Kreike, R Willemze, C J Meijer.   

Abstract

Homeobox (HOX) genes are involved in the lineage-specific differentiation of bone marrow stem cells. Recently, we reported a largely similar expression pattern of HOXC4 and HOXC6 in normal and neoplastic cells of the lymphoid lineage. In contrast, HOXC5 was specifically expressed in a subset of B-cell non-Hodgkin's lymphomas (B-NHL) but not in normal lymphocytes or lymphoid leukemias. This might suggest a role for HOXC5 in the pathogenesis of these lymphomas. In the present study the expression of HOXC4, HOXC5, and HOXC6 in primary cutaneous lymphomas was investigated. Using RNA in situ hybridization (RISH) and semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR), we found strong expression of HOXC4 and HOXC6 in all, except one, primary cutaneous lymphomas and all reactive cutaneous lymphoid infiltrates. Interestingly, a strong expression of HOXC5 in primary anaplastic CD30+ large T-cell lymphomas was found. RISH was consistently negative for HOXC5 in all other types of primary cutaneous B- and T-cell lymphomas. However, by semiquantitative RT-PCR these lymphomas showed a weak expression of HOXC5 mRNA. Therefore, we concluded that these lymphomas express low constitutive levels of HOXC5 mRNA. Furthermore, HOXC5 expression was consistently absent in reactive cutaneous lymphoid infiltrates, hyperplastic tonsils and lymph nodes, and peripheral blood lymphocytes either unstimulated or stimulated by a cocktail of CD3 and CD28 antibodies. As a strong expression of HOXC5 in primary cutaneous lymphomas was observed only in anaplastic large T-cell lymphomas and reactive control tissues lacked HOXC5 expression, these data strongly support a role for HOXC5 in the genesis of anaplastic large-T-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327740      PMCID: PMC1858029     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

Review 1.  Homeobox genes in normal hematopoiesis and leukemia.

Authors:  H J Lawrence; C Largman
Journal:  Blood       Date:  1992-11-15       Impact factor: 22.113

Review 2.  Hox codes and positional specification in vertebrate embryonic axes.

Authors:  P Hunt; R Krumlauf
Journal:  Annu Rev Cell Biol       Date:  1992

3.  Hox proteins have different affinities for a consensus DNA site that correlate with the positions of their genes on the hox cluster.

Authors:  I Pellerin; C Schnabel; K M Catron; C Abate
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

4.  Identification of homeobox genes expressed in human T-lymphocytes.

Authors:  K Inamori; K Takeshita; S Chiba; Y Yazaki; H Hirai
Journal:  Biochem Biophys Res Commun       Date:  1993-10-15       Impact factor: 3.575

5.  Expression of HOX C homeobox genes in lymphoid cells.

Authors:  H J Lawrence; K M Stage; C H Mathews; K Detmer; R Scibienski; M MacKenzie; E Migliaccio; E Boncinelli; C Largman
Journal:  Cell Growth Differ       Date:  1993-08

6.  Binding and transcriptional activation of the promoter for the neural cell adhesion molecule by HoxC6 (Hox-3.3).

Authors:  F S Jones; B D Holst; O Minowa; E M De Robertis; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

7.  Expression of homeobox-containing genes in primary and metastatic colorectal cancer.

Authors:  G De Vita; P Barba; N Odartchenko; J C Givel; G Freschi; G Bucciarelli; M C Magli; E Boncinelli; C Cillo
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

8.  Functional specificity of the homeodomain protein fushi tarazu: the role of DNA-binding specificity in vivo.

Authors:  A F Schier; W J Gehring
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

9.  HOX gene expression in normal and neoplastic human kidney.

Authors:  C Cillo; P Barba; G Freschi; G Bucciarelli; M C Magli; E Boncinelli
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

10.  Characteristic patterns of HOX gene expression in different types of human leukemia.

Authors:  A Celetti; P Barba; C Cillo; B Rotoli; E Boncinelli; M C Magli
Journal:  Int J Cancer       Date:  1993-01-21       Impact factor: 7.396

View more
  3 in total

1.  Ectopic expression of HOXC6 blocks myeloid differentiation and predisposes to malignant transformation.

Authors:  Melanie Wurm; John Kowalski; Dirk Heckl; Xiao-Bing Zhang; Veronica Nelson; Brian C Beard; Hans-Peter Kiem
Journal:  Exp Hematol       Date:  2013-10-26       Impact factor: 3.084

2.  A Genetic Screen for Human Genes Suppressing FUS Induced Toxicity in Yeast.

Authors:  Elliott Hayden; Shuzhen Chen; Abagail Chumley; Chenyi Xia; Quan Zhong; Shulin Ju
Journal:  G3 (Bethesda)       Date:  2020-06-01       Impact factor: 3.154

3.  HOXC4 up-regulates NF-κB signaling and promotes the cell proliferation to drive development of human hematopoiesis, especially CD43+ cells.

Authors:  Jiahui Zeng; Wencui Sun; Jing Chang; Danying Yi; Lijiao Zhu; Yonggang Zhang; Xu Pan; Ya Zhou; Mowen Lai; Guohui Bian; Qiongxiu Zhou; Jiaxin Liu; Bo Chen; Feng Ma
Journal:  Blood Sci       Date:  2020-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.